In summary, these findings supported our hypothesis that cNFIB prevented the interaction between MEK1 and ERK2 by competitively binding to MEK1, thereby downregulating ERK phosphorylation and inhibiting ICC progression. The gene discussed is MAPK1; the disease is intrahepatic cholangiocarcinoma.